Beni Surpin is a partner in the firm’s Life Sciences group, where he focuses on global technology and commercial transactions. Beni counsels international and domestic companies on a variety of legal and business issues in complex technology, intellectual property, and commercial deals across a wide range of industries, including in the life sciences, medical devices, healthcare, wireless, high-tech, automotive, aviation, food and beverage, and fashion and apparel sectors. His practice centers on complex collaborations between companies involving technology transfer and licenses, at all stages from inception to full commercialization, to generate and enhance product lines and services through access to new technologies. He works closely with clients in creating and setting strategic direction and then structuring relationships and negotiating deals to implement these goals.
Beni’s experience covers a broad spectrum of deals and structures through collaborations, licenses and acquisitions, service-based platforms, manufacturing, supply and distribution arrangements, clinical, services, and research and development agreements, joint ventures, and strategic partnerships and alliances. He also works with private and public companies to maximize value and revenue from intellectual property and technology portfolios in a way that allows companies to optimize their assets, advising clients on a variety of related legal and business issues.
With additional experience in the areas of corporate governance and business, private equity, leveraged debt financing, and real estate investments and funds, he also guides emerging growth entities, middle market companies, and multinational corporations in their strategic planning, development and growth.
